These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9285833)
1. [Anti-allergic activity of betotastine besilate (TAU-284), a new anti-allergic drug]. Yato N; Murata T; Saito N; Sakai A; Kikuchi M; Tsuzurahara K; Narita H Nihon Yakurigaku Zasshi; 1997 Jul; 110(1):19-29. PubMed ID: 9285833 [TBL] [Abstract][Full Text] [Related]
2. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen. Ueno M; Inagaki N; Nagai H; Koda A Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778 [TBL] [Abstract][Full Text] [Related]
3. [Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis]. Murata T; Matsumoto Y; Suzuki T; Naito K; Takata I; Tsuzurahara K Arerugi; 1997 Jul; 46(7):576-84. PubMed ID: 9301130 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate. Kato M; Nishida A; Aga Y; Kita J; Kudo Y; Narita H; Endo T Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705 [TBL] [Abstract][Full Text] [Related]
5. A novel anti-allergic drug, betotastine besilate, suppresses interleukin-5 production by human peripheral blood mononuclear cells. Kaminuma O; Ogawa K; Kikkawa H; Kikuchi M; Naito K; Ikezawa K Biol Pharm Bull; 1998 Apr; 21(4):411-3. PubMed ID: 9586584 [TBL] [Abstract][Full Text] [Related]
6. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist]. Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558 [TBL] [Abstract][Full Text] [Related]
8. Anti-allergic actions of the leaves of Castanea crenata and isolation of an active component responsible for the inhibition of mast cell degranulation. Lee E; Choi EJ; Cheong H; Kim YR; Ryu SY; Kim KM Arch Pharm Res; 1999 Jun; 22(3):320-3. PubMed ID: 10403140 [TBL] [Abstract][Full Text] [Related]
9. [Antiallergic effects of a novel compound, SWR-00151]. Tanaka Y; Masai E; Yashima T; Furukawa M Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of betotastine besilate on antigen-induced airway eosinophil infiltration and peripheral blood eosinophilia in mice. Sakai A; Kikuchi M; Yato N; Kikkawa S; Saito N; Narita H Arzneimittelforschung; 1997 Aug; 47(8):954-8. PubMed ID: 9296282 [TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675 [TBL] [Abstract][Full Text] [Related]
13. Anti-allergic action of buckwheat (Fagopyrum esculentum Moench) grain extract. Kim CD; Lee WK; No KO; Park SK; Lee MH; Lim SR; Roh SS Int Immunopharmacol; 2003 Jan; 3(1):129-36. PubMed ID: 12538043 [TBL] [Abstract][Full Text] [Related]
14. [Anti-allergic effects of Rubus suavissimus extract]. Fang YG; Lu HW; Feng JH; Bao L; Kurihara H Zhong Yao Cai; 2008 May; 31(5):710-4. PubMed ID: 18826149 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057 [TBL] [Abstract][Full Text] [Related]
16. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860 [TBL] [Abstract][Full Text] [Related]
17. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models. Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367 [TBL] [Abstract][Full Text] [Related]
18. Antiallergic effects of ZCR-2060: effect on allergic cutaneous reactions and rhinitis models in mice and rats. Abe T; Omata T; Yoshida K; Segawa Y; Matsuda K; Nagai H Jpn J Pharmacol; 1994 Sep; 66(1):95-103. PubMed ID: 7532246 [TBL] [Abstract][Full Text] [Related]
19. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis. Tan JW; Israf DA; Harith HH; Md Hashim NF; Ng CH; Shaari K; Tham CL Toxicol Appl Pharmacol; 2017 Mar; 319():47-58. PubMed ID: 28167223 [TBL] [Abstract][Full Text] [Related]
20. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate. Nabe T; Yamamura H; Kohno S; Ohata K Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]